20-21161882-C-G
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_018474.6(KIZ):āc.417C>Gā(p.His139Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.656 in 1,607,958 control chromosomes in the GnomAD database, including 352,336 homozygotes. In-silico tool predicts a benign outcome for this variant. 10/13 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt. Synonymous variant affecting the same amino acid position (i.e. H139H) has been classified as Likely benign.
Frequency
Consequence
NM_018474.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIZ | NM_018474.6 | c.417C>G | p.His139Gln | missense_variant | 5/13 | ENST00000619189.5 | NP_060944.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIZ | ENST00000619189.5 | c.417C>G | p.His139Gln | missense_variant | 5/13 | 1 | NM_018474.6 | ENSP00000479542.1 |
Frequencies
GnomAD3 genomes AF: 0.580 AC: 87862AN: 151470Hom.: 27079 Cov.: 30
GnomAD3 exomes AF: 0.646 AC: 160031AN: 247878Hom.: 53158 AF XY: 0.664 AC XY: 89208AN XY: 134412
GnomAD4 exome AF: 0.664 AC: 967574AN: 1456376Hom.: 325246 Cov.: 33 AF XY: 0.671 AC XY: 486456AN XY: 724726
GnomAD4 genome AF: 0.580 AC: 87914AN: 151582Hom.: 27090 Cov.: 30 AF XY: 0.585 AC XY: 43338AN XY: 74054
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Retinal dystrophy Benign:1
Benign, criteria provided, single submitter | research | Dept Of Ophthalmology, Nagoya University | Oct 01, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at